Medicines in Development
Tasly Pharmaceuticals, Inc. has a portfolio of therapeutic programs in development focused on addressing unmet medical needs across multiple disease areas, including cardiovascular, liver, oncology, immunology, and stem cell–related research, with an emphasis on advancing botanical and related therapeutic approaches.
| Areas | Program | Classification | Indication | Development Stage | Status | ||||
|---|---|---|---|---|---|---|---|---|---|
| PRE-CLINICAL | PHASE I | PHASE II | PHASE III a | PHASE III b | |||||
| Cardiovascular | T89 | Herbal | Chronic stable angina | Phase III trial completed | |||||
| Cardiovascular | T89 | Herbal | Chronic stable angina | Phase III ORESA study ongoing |
|||||
| Cardiovascular | T89 | Herbal | Acute mountain sickness (AMS) | Completed | |||||